Rebalance of Striatal NMDA/AMPA Receptor Ratio Underlies the Reduced Emergence of Dyskinesia During D2-Like Dopamine Agonist Treatment in Experimental Parkinson's Disease

Dopamine replacement with levodopa (l-DOPA) represents the mainstay of Parkinson's disease (PD) therapy. Nevertheless, this well established therapeutic intervention loses efficacy with the progression of the disease and patients develop invalidating side effects, known in their complex as l-DO...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :J Neurosci
Главные авторы: Bagetta, Vincenza, Sgobio, Carmelo, Pendolino, Valentina, Del Papa, Giulia, Tozzi, Alessandro, Ghiglieri, Veronica, Giampà, Carmela, Zianni, Elisa, Gardoni, Fabrizio, Calabresi, Paolo, Picconi, Barbara
Формат: Artigo
Язык:Inglês
Опубликовано: Society for Neuroscience 2012
Предметы:
Articles
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC6621675/
https://ncbi.nlm.nih.gov/pubmed/23223310
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1523/JNEUROSCI.2664-12.2012
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы